Evidence map›Paper›PMID 42100384›Full record

SynthesisFrontiers in oncology2026

Association between map-like redness and the risk of gastric cancer and high-risk precancerous lesions: a systematic review and meta-analysis.

Baixiang He, Mingyue Liu, Xiaochi Ma, Sheng Huang, Xiangyun Zou, Liju Zhang, Xiyan Zhang, Tong Li, Jinglin Zhang, Zhihong Li

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Baixiang He *Gastroenterology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Mingyue Liu *Dermatology Department, Xiyuan Hospital, Beijing, China.
Xiaochi Ma *Gastroenterology Department, The First Affiliated Hospital, Henan University of Chinese Medicine, Zhengzhou, China.
Sheng HuangGastroenterology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Xiangyun ZouGastroenterology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Liju ZhangGastroenterology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Xiyan ZhangGastroenterology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Tong LiGastroenterology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Jinglin ZhangGastroenterology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Zhihong LiGastroenterology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: The risk of gastric cancer (GC) following Methods: We conducted a systematic search in PubMed, Embase, the Cochrane Library, CNKI, Wanfang, CBM, and VIP databases up to April 23, 2025. The primary outcome was GC, and secondary outcomes were high-risk precancerous lesions defined as the Operative Link on Gastritis Assessment (OLGA) stage > II, Gastric Intestinal Metaplasia Assessment (OLGIM) stage > II, and Kimura-Takemoto (K-T) classification > C2. Results: 14 studies were included (10 for GC, 2 for OLGA, 3 for OLGIM, and 3 for K-T classification). A significant association was observed between MLR and GC (ORs 4.38; 95% CI 3.45-5.57; I Conclusion: MLR is highly associated with an increased risk of GC and high-risk precancerous lesions. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420251048039, identifier CRD420251048039.

Indexed as

endoscopic markergastric cancermap-like rednessmeta-analysispost-Helicobacter pylori eradication

Identifiers

PMID42100384
PMCPMC13143535

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.